Expression of the Wilms' tumor gene Wt1 in the epicardium is critical for normal heart development. Mouse embryos with inactivated Wt1 gene have extremely thin ventricles, which can result in heart failure and death. Here, we demonstrate that Wt1 can be activated in adult hearts by local ischemia. Wt1 mRNA was increased more than twofold in the left ventricular myocardium of rats between 1 day and 9 wk after infarction. Wt1 expression was localized by means of mRNA in situ hybridization and immunohistochemistry to vascular endothelial and vascular smooth muscle cells in the border zone of the infarcted tissue. A strikingly similar distribution was seen for vascular endothelial growth factor and two different cell proliferation markers in the coronary vessels of the ischemic heart. No Wt1 could be detected in the vasculature of the noninfarcted right ventricles. Wt1 expression in the coronary vessels of the ischemic heart was mimicked by exposure of rats to normobaric hypoxia (8% O 2 ) and 0.1% CO, respectively. These findings demonstrate that Wt1 is expressed in the vasculature of the heart in response to local ischemia and hypoxia. They suggest that Wt1 has a role in the growth of coronary vessels after myocardial infarction. The gene consists of 10 exons and encodes a zinc-finger protein of the C 2 H 2 type, which is similar to the early growth response (egr) family of transcription factors (see ref 3 for review).
Notably, Wt1 was not only identified as a suppressor of malignant cell growth, but also as a critical regulator of organogenesis. Thus, mouse embryos with homozygous Wt1 null alleles fail to develop kidneys, gonads, spleens, and adrenal glands, and they exhibit severe defects in mesothelial tissues (19) (20) (21) . Based on its spatio-temporal expression in wild types (22) (23) (24) (25) , and the characteristic phenotype of the Wt1 -/-mutants (19) , Wt1 was proposed to enable cells to flip between a mesenchymal and epithelial state (21) . Strikingly, the Wt1 -/-embryos develop an extremely thin myocardium, which sometimes consists of no more than a single layer of cells (19, 21) . Furthermore, they exhibit disruption of the epicardium, which is missing over much of the cranial surface of the ventricles (19, 21) . It is interesting to note that Wt1 is expressed in the epicardial layer but not in the myocardium of normal individuals (19, 26) . This suggests that the failure of the Wt1 -/-hearts to develop normally is due to impaired signaling of the disrupted epicardium rather than resulting from a cell autonomous growth defect of the cardiac myocytes. As a likely consequence of the epicardial malformations, the Wt1 -/-embryos frequently show bleeding into the pericardial space and die before end-gestation, presumably from heart failure (19, 21) .
Hypertrophy of the heart as a result of enhanced myocardial growth is a major risk factor for cardiovascular mortality. The molecular mechanisms that underlie the hypertrophic response of the myocardium are incompletely understood. However, up-regulation of genes that are expressed in the developing heart is a common theme in cardiac hypertrophy (see ref 27 for review). It was therefore proposed that the same transcription factors are involved in early cardiac cell development and in the growth of adult cardiac myocytes (27) .
Because Wt1 is essential for normal growth of the heart during embryogenesis, we reasoned that it might also play a role in adult cardiac hypertrophy. To test this hypothesis, we analyzed the expression of Wt1 in normal hearts and in the hypertrophied left ventricles of spontaneously hypertensive rats (SHRs), with activation of the renin-angiotensin system by transgenic (over) expression of human renin and angiotensinogen genes, and with postinfarct remodeling of the heart after ligation of the left coronary artery (LAD).
MATERIALS AND METHODS

Animals
Male rats weighing 250-280 g were obtained from the local animal house. The reninangiotensinogen double-transgenic rats (TGRs) are described in detail elsewhere (28) . The TGRs carried the complete human angiotensinogen gene with 1.6 kb of the 5'-flanking region and 3.5 kb of the 3'-flanking sequence, as well as the full-length human renin gene, including 3 kb of upstream promoter region and 1.2 kb of downstream sequence (28) . Both transgenes are expressed in the myocardium of these rats, which exhibit severe Ang II-dependent arterial hypertension and left ventricular hypertrophy (28) . The SHRs were obtained from Charles River (Sulzfeld, Germany).
Induction of myocardial infarction
This study conforms to the Guide for the Care and Use of Laboratory Animals (Academic Press). Myocardial infarction was established under chloralhydrate anesthesia (400 mg/kg) in 6-wk-old male rats (n=80, body weight of 250-280 g) by ligating the LAD as described in detail previously (29) . Sham-operated animals (n=20) underwent the same surgical procedure but without ligation of the LAD. The survival rates during the first 24 h after surgery were 100% and 25% among sham-operated rats and animals with coronary artery ligation, respectively. The surviving rats with ligated LAD and the sham-operated animals were randomly assigned to different groups (n=5 each). At various time points (24 h and 3, 6, and 9 wk) after cardiac surgery, the animals were deeply anesthetized with ether, and their hearts were quickly excised. The left and right ventricles were prepared and weighed separately. To estimate the infarct size, the portion of the left ventricular endocardial circumference that was either necrotic (24 h after infarction) or replaced by scar tissue (3-9 wk after infarction) was determined. Tissue specimens from the left and right ventricles were snap-frozen in liquid nitrogen and stored at -80ºC for additional processing.
RNase protection assay
A sensitive RNase protection assay method was used to measure Wt1 mRNA in rat hearts. For this purpose, total RNA was isolated separately from the left and right ventricles with Trizol reagent (Life Technologies). Antisense riboprobes were labeled with 32 P-UTP (250 Ci/mmol, ICN Biomedicals) to specific activities of 5×10 8 cpm/µg by in vitro transcription with SP6 and T7 RNA polymerase (MaxiScript kit, Ambion, Austin, TX) from 1 µg of linearized template DNA. The template for the Wt1 riboprobe consisted of a 271-bp sequence spanning between exons 4 and 7 of the rat Wt1 cDNA (30) . This probe was expected to yield protected RNA fragments of 271 and 220 nucleotides corresponding to the alternatively spliced Wt1(+17aa) and Wt1(-17aa) variants.
The DNA template was generated by reverse transcriptase-polymerase chain reaction (RT-PCR) of total RNA (5 µg) from adult rat kidney with the use of the following gene-specific oligonucleotide primers: 5'-CTCCTGCAGACCAGATGAACCTCGGAG-3' (forward primer), 5'-CTCGGATCCCTGGGTACGCACACATGA-3' (reverse primer). Correct identity of the PCR product, which was ligated between the BamH I and Pst I restriction sites of the pGEM-4Z plasmid (Promega), was confirmed by dideoxy sequencing of both strands. An antisense riboprobe for U6 small nuclear (sn) RNA, yielding a 106-bp protected fragment (nucleotides 1-107, accession no. X01366) was kindly provided by Dr. P. Ratcliffe.
RNase protection assays were performed as described previously for the human and mouse Wt1 genes (31) . In brief, 10 µg and 1 µg of the sample RNA were hybridized with 5×10 5 cpm of Wt1 antisense and U6 sn RNA probes, respectively. The total RNA content in the reaction mixtures was adjusted to 50 µg by adding the appropriate amounts of yeast transfer RNA (Boehringer Biochemicals, Mannheim, Germany). The volume of the hybridization samples was 50 µl in a buffer consisting of 80% formamide, 40 mM Pipes buffer, pH 6.4, 400 mM NaCl, and 1 mM EDTA. Overnight hybridization was performed at 55ºC in parallel with Wt1 antisense and U6 sn RNA probes. The next day, the samples were first incubated for 30 min at 25ºC with 350 µl RNase A/T1 (Boehringer Biochemicals). A 100-fold stock solution of the RNase mixture was prepared by dissolving 200 mg RNase T1 (Boehringer Biochemicals) and 4 mg RNase A (Boehringer Biochemicals) in 1 ml of RNase buffer (200 mM NaCl, 5 mM EDTA, 10 mM TrisCl, pH 7.5). After RNase digestion, the samples were treated for 30 min at 37ºC with 0.15 mg/ml proteinase K in 0.5% sodium dodecyl sulfate.
As an internal control for RNA quantification, one-tenth of the samples hybridized with the U6 sn RNA (0.1 µg) was combined with the samples that were hybridized with the Wt1 antisense probe. After extraction with buffered phenol/chloroform solution, the protected RNA fragments were first precipitated with ethanol and then resuspended in gel loading buffer (80% formamide, 1× TBE, 0.1% bromophenol blue, 0.1% xylene cyanol). The samples were heated to 95ºC for 5 min and run on a denaturing 8% polyacrylamide gel in 1× TBE buffer (300 V, 3 h). Samples under certain experimental conditions together with the appropriate controls were always analyzed in parallel and run on the same gel. The dried gel was autoradiographed at -80ºC. The intensity of the hybridization signals was determined by densitometric scanning of the autoradiographs (Microtek scanner, Imagequant software). The signal ratio of protected Wt1 and U6 sn RNA fragments was calculated after background subtraction.
Immunohistochemistry
Snap-frozen tissue samples were embedded in Tissue-Tek O.C.T. compound (Sakura Finetek). Tissue sections (10 µm) were cut and transferred onto gelatin-coated glass slides. The tissue was permeabilized with 0.1% Triton X-100 in phosphate-buffered saline (PBS) and blocked by incubation for 1 h in 10% normal goat serum (in PBS, 0.1% Triton X-100, 3% bovine serum albumin [BSA] ). Following treatment (16 h, 4°C) with primary anti-Wt1 polyclonal antibody (C-19, cat.# sc-192, Santa Cruz Biotechnology, Santa Cruz, CA) diluted 1:150 (in PBS, 1% BSA) and three 15-min washes in PBS, the sections were incubated for 1.5 h with biotinylated secondary antibody (1:150 dilutions in PBS, 1% BSA, Vector Laboratories) and streptavidinCy3 complex (Sigma, Deisenhofen, Germany). The sections were viewed under an epifluorescence microscope (Axioplan 2, Zeiss), which was connected to a digital camera (Spot RT Slider, Diagnostic Instruments) with the use of Metamorph V4.1.2 software (Universal Imaging).
For double-immunolabeling of Wt1 and a second protein, the tissue sections were first incubated for 16 h at 4°C with one of the following primary antibodies: anti-proliferating cell nuclear antigen (PCNA) monoclonal antibody (PC10, cat.# sc-56, Santa Cruz Biotechnology) diluted 1:150 (in PBS, 0.1% BSA), anti-hypoxia-inducible factor-1 (HIF-1)α polyclonal antibody diluted 1:100 (cat.# sc-8711, Santa Cruz Biotechnology), anti-platelet/endothelial cell adhesion molecule-1 (PECAM-1) polyclonal antibody diluted 1:100 (cat.# sc-1506, Santa Cruz Biotechnology), anti-vascular endothelial growth factor (VEGF) polyclonal antibody diluted 1:100 (cat.# G121, Santa Cruz Biotechnology), and anti-smooth muscle α-actin monoclonal antibody diluted 1:300 (cat.# A2547, Sigma).
Following treatment with primary antibody, the tissue sections were washed in PBS and then incubated for 1.5 h with FITC-conjugated specific Fab-fragments (Dianova). After three 15-min washes in PBS, the tissue sections were incubated with anti-Wt1 rabbit polyclonal antibody (1:150 dilution in PBS, 10% normal goat serum, Santa Cruz Biotechnology) overnight at 4°C and were then treated with biotinylated secondary antibody (1:150 dilution in PBS, 1% BSA, Vector Laboratories.) and Cy3-streptavidin complex (Sigma). The yellow staining of cells upon merging the green and red fluorescence signals indicated colocalization of both proteins. Incubating tissue sections from infarcted rat hearts with diluted normal serum instead of primary antibody was performed as an appropriate negative-control. Counterstaining with DAPI was done to visualize the nuclei.
Nonradioactive mRNA in situ hybridization
Nonradioactive mRNA in situ hybridization was carried out on 10-µm paraformaldehyde (3% in PBS) fixed cryostat sections of cardiac tissue as described by Braissant and Wahli (32) . In brief, digoxigenin-labeled RNA probes were synthesized by in vitro transcription with SP6 RNA polymerase (Roche Molecular Biochemicals) from linearized template DNA. Sense RNA transcripts were generated from the same template with the use of T7 RNA polymerase (Roche Molecular Biochemicals). Hybridization was performed for 48 h at 58°C in a 50% formamide, 5× SSC solution supplemented with 60 µg/ml of salmon sperm DNA (Promega). The tissue sections were washed at high stringency (1 h in 0.1× SSC at 65°C), and mRNA hybrids were detected by incubation with alkaline phosphatase-coupled anti-digoxigenin antibody and staining with NBT/BCIP (Roche Molecular Biochemicals). Stained tissue sections were viewed under an Axiovert S100 microscope (Zeiss).
Statistical analysis
Values are expressed as mean ±SE. Intergroup comparisons of mRNA measurements were done using a one-way ANOVA with the Bonferroni test as a post hoc test. Values of P<0.05 were considered statistically significant.
RESULTS
Cardiac hypertrophy of SHRs and of the TGRs is indicated by their increased ratios of left ventricular weight to body weight, which were 3.8±0.04 and 4.1±0.08 mg/g, respectively, compared with 2.1±0.03 mg/g in normal rats (mean ±SE, n=5 each). Enhanced cardiac growth of the SHRs and TGRs also has previously been demonstrated by means of morphometric measurements of increased cardiomyocyte size (28) . The left ventricular weight to body weight ratios were 2.0±0.04 mg/g in sham-operated rats and 2.7±0.02 mg/g in rats 6 wk after ligation of the LAD. Compensatory hypertrophy of the remaining myocardium after infarction (41±2% mean infarct size) is consistent with our previous findings (29, 33) .
Wt1 mRNA in normal and hypertrophied rat hearts
Wt1 mRNA was determined with the use of RNase protection assay in the left ventricles of normal rats and of rats with cardiac hypertrophy (n=5 in each group). For normalization of Wt1 expression, the housekeeping gene U6 sn RNA was measured in parallel in each sample. A representative autoradiogram of a RNase protection assay is shown in Figure 1 . Wt1 transcripts were similar in the hearts of normal Wistar Kyoto (WKY) rats and in the hypertrophied left ventricles of TGRs and SHRs, respectively. However, Wt1 mRNA was increased more than twofold in the left ventricular myocardium of rats 6 wk after ligation of the LAD.
Wt1 expression in the infarcted rat hearts
To study Wt1 expression in the infarcted rat hearts in more detail, we measured its mRNA at different time intervals after LAD ligation. Compared with sham-operated rats, Wt1 mRNA was increased between 2.5-and 3-fold in the left ventricular myocardium 24 h after ligation of the LAD ( Fig. 2A, 2B ). Wt1 transcripts remained elevated during 9 wk after myocardial infarction. No significant differences in Wt1 mRNA were detected between the noninfarcted right ventricles of LAD-ligated and sham-operated rats at variable time points after surgery (Fig. 2C ).
Immunohistochemistry and mRNA in situ hybridization were performed to identify the cellular sites of Wt1 expression in the hearts of sham-operated rats and of rats with LAD ligation. Approximately 80 tissue sections from five different animals in each group were examined. In good agreement with previous studies (21, 26), we detected Wt1 in the epicardium but not in the myocardial tissue of the sham-operated animals (Fig. 3e) . Most interestingly, in addition to the epicardial layer, Wt1 mRNA and protein were also seen in the coronary vasculature as early as 24 h after ligation of the LAD (Fig. 3c, d , f-h). Wt1 immunoreactivity persisted in the vascular walls at least until 9 wk after myocardial infarction (data not shown). Strikingly, Wt1 expression was present only in coronary vessels that were located in close proximity to the infarcted tissue but not in the more distant vasculature (Fig. 3f) . Wt1 was not expressed in the myocardial vessels of the noninfarcted right ventricles (data not shown).
To further characterize the cell type(s) that expressed Wt1 in the coronary vasculature after myocardial infarction, we made use of a double-immunofluorescent labeling technique (Fig. 4) . Staining of vascular smooth muscle cells (VSMCs) was done with a polyclonal antibody against smooth muscle α-actin. Vascular endothelial cells were marked by immunolabeling of PECAM-1. Colocalization of Wt1 (red) and smooth muscle α-actin (green) is indicated by the intense yellow fluorescence of cells that contained both proteins (Fig. 4b, c) . The green fluorescence in the wall of the coronary vessel shown in Figure 4c demonstrates that not all smooth muscle α-actin-positive cells also contained Wt1. However, a specific Wt1 fluorescence signal (red) was detected in smooth muscle α-actin-negative cells that were lining the luminal circumference of the coronary vessels in the border zone of the infarcts (Fig. 4c) . The Wt1-expressing cells in the inner portion of the myocardial vessels were identified as endothelial cells on the basis of their staining with anti-PECAM-1 antibody (Fig. 4e, f) . The PECAM-1 fluorescence signal was weaker in sham-operated rat hearts and in the noninfarcted right ventricles of rats with LAD ligation (data not shown). No overlapping expression of PECAM-1 and Wt1 was detected in the hearts of sham-operated rats. These findings indicate that VSMCs as well as vascular endothelial cells in the border zone of the infarcts are capable of Wt1 expression.
The overlapping distribution of PECAM-1 and Wt1 is remarkable, because PECAM-1 has been implicated in vascular development (34) (35) (36) . This raises the interesting possibility that local upregulation of Wt1 in the coronary vasculature was related to vascular cell proliferation and the formation of new blood vessels in response to regional tissue ischemia. In support of such an idea, we observed a strikingly similar expression pattern of PCNA and Wt1 in the vasculature of the infarcted rat hearts (Fig. 5b, c) . Whereas PCNA-positive cells were intensely marked in coronary vessels of the ischemic left ventricles 24 h after LAD ligation (Fig. 5b, c) , only weak labeling was detected in a few coronary vessels in the sham-operated rats (data not shown).
VSMCs and vascular endothelial cells are normally quiescent in adult arteries. Mitosis of these cells is critical for the growth of collaterals from preexisting vessels. VEGF is one of the humoral mediators that have been implicated in coronary collateralization (37) (38) (39) . To investigate whether Wt1 and VEGF were colocalized in the myocardial vessels of the infarcted rat hearts, we performed double-immunofluorescent labeling of both proteins on tissues sections 24 h after ligation of the LAD. Figure 5 shows that the distribution of VEGF and Wt1 was strikingly similar in coronary vessels from the infarcted left ventricles. For comparison, no VEGF immunoreactivity was seen in sham-operated rats and in the nonischemic right ventricles of the LAD-ligated animals (data not shown).
Stimulation of Wt1 expression in rat hearts by hypoxia
The early onset of Wt1 after coronary artery occlusion suggests that its expression was stimulated by local tissue ischemia. Because reduced tissue oxygenation is a major component of ischemia, we examined whether enhanced expression of Wt1 after LAD ligation could be mimicked by hypoxia. Two well-established procedures, normobaric hypoxia with an inspiratory oxygen fraction of 8% O 2 (n=9) and exposure of rats to a 0.1% CO atmosphere (n=5), were used to reduce the oxygen supply to the tissues. Figure 6A shows a representative autoradiogram of a RNase protection assay measuring Wt1 mRNA in the left ventricles of rats after 6 h of exposure to either 8% O 2 or 0.1% CO, respectively. A more than fourfold increase in cardiac Wt1 mRNA was found in hypoxic (8% O 2 , 0.1% CO) compared with normoxic (20% O 2 ) rat hearts. The abundance of U6 sn RNA was similar between the different experimental protocols. It is of interest that Wt1 mRNA was also increased in the kidneys after 6 h of hypoxic exposure, suggesting that hypoxic regulation of Wt1 is not restricted to myocardial vessels (Wagner et al., unpublished observations).
Immunofluorescent staining was performed to mark the Wt1-expressing cells in the hypoxic rat hearts. Very similar to the ischemic myocardium, Wt1 immunoreactivity was detected in the coronary vasculature of rats that were exposed either to 8% O 2 or to 0.1% CO. However, vascular Wt1 expression was not restricted to certain regions in the hypoxic hearts but was extended to the coronary vessels of both left and right ventricles. HIF-1 is a master regulator of oxygen-dependent gene transcription (see refs 40 and 41 for review). To further establish a role for reduced tissue oxygenation in Wt1 expression after myocardial infarction, we examined whether the oxygen-sensitive HIF-1α subunit colocalized with Wt1 in the coronary vasculature of the ischemic rat hearts. A representative example (n=3) of double-immunolabeling of Wt1 (red) and HIF-1α (green) in coronary vessels close to the infarcted tissue (24 h after LAD ligation) is shown in Figure 6e . As indicated by the intense yellow fluorescence signal, the two proteins were coexpressed, in part, in the vasculature of the ischemic myocardium. Counterstaining with DAPI revealed the nuclear expression of HIF-1α (Fig. 6f) . HIF-1α could not be detected in the noninfarcted right ventricles and in the hearts of sham-operated rats.
DISCUSSION
The original aim of this study was to investigate whether Wt1 has a role in cardiac hypertrophy. This hypothesis is based on two facts: First, the phenotype of mice with inactivated Wt1 gene indicates a requirement for Wt1 in normal growth of the developing heart (19, 21); second, cardiac hypertrophy is frequently associated with the revival of "fetal" genes, suggesting that the transcriptional mechanisms for cardiac growth are similar in embryonic and adult hearts (see ref 27 for review).
However, in contrast to our original hypothesis, the lack of response of Wt1 in the hypertrophied left ventricles of spontaneously hypertensive rats and of rats with activated renin-angiotensin system argues against a close relationship between Wt1 expression and cardiac growth. Even though the expression of Wt1 was clearly enhanced in the heart after coronary artery occlusion, its early onset and restriction to coronary vessels do not support a role for hypertrophic stimuli in the control of cardiac Wt1 expression. Instead, our findings suggest that up-regulation of Wt1 is part of the genomic response of the myocardium to regional tissue ischemia.
Some of the most obvious questions that arise from our findings are the following: How can it be explained that coronary vascular cells are capable of expressing Wt1? Which are the signals that stimulate Wt1 expression in the coronary vasculature after myocardial infarction? What is the functional significance of Wt1 expression in coronary vessels after cardiac ischemia? To find reasonable answers to these questions, it is helpful to recall briefly the spatial and temporal expression of Wt1 in the developing heart. During cardiogenesis in the mouse embryo, Wt1 is initially detected at gestational day 9 (E9) in the proepicardial mesenchymal villi on the cranial surface of the septum transversum (21) . Subsequently, these Wt1-positive cells migrate across the pericardial cavity and spread over the surface of the myocardium to form the epicardial layer (21) . Between E11.5 and E12.5, Wt1-expressing cells begin to delaminate from the epicardium into the subepicardial zone, where they form a layer of subepicardial mesenchymal cells (SEMCs) (21) . Wt1 is thought to play a crucial role in this process by allowing epicardial cells to undergo epithelial-to-mesenchymal transition. The idea that Wt1 is important for the shift between mesenchyme and epithelium as well as between epithelium and mesenchyme (21) is based on the characteristic phenotype of the Wt1 null mutants.
Among other organ malformations, mouse embryos with deficient Wt1 gene exhibit severe defects in the epicardial layer (19, 21) and lack most of their SEMCs (21) . The few remaining SEMCs in the mutant embryos do not migrate into the myocardium (21) . Furthermore, Wt1 -/-mice also show a failure in normal formation of the diaphragm, which also, in part, is composed of cells derived from the septum transversum of the proepicardial organ (21) . In wild-type mice around E12.5, Wt1-positive cells, in particular at the caudal regions of the intraventricular sulcus, migrate from the SEMC zone into the myocardium. Here they give rise to coronary VSMCs, perivascular and intermyocardial fibroblasts, and possibly vascular endothelial cells (42) (43) (44) (45) . Wt1 expression is switched off once these cells have become fully differentiated (21) .
Notably, we observed a strikingly similar spatial distribution of Wt1, smooth muscle α-actin, and PECAM-1 in the coronary vasculature of the ischemic myocardium. These findings indicate that VSMCs as well as endothelial cells in adult hearts are capable of Wt1 expression. We assume that the Wt1-positive cells in the myocardial vessels originate from epicardium-derived mesenchymal cells that become part of the coronary vasculature during cardiogenesis (42) (43) (44) (45) . To verify this hypothesis, it will be helpful to follow the fate of the Wt1-positive cells in the developing heart. This goal can be accomplished with the use of recently established transgenic mouse lines that express a lacZ reporter under control of the human WT1 locus (21, 26) . Strikingly, expression of the transgene in these lines faithfully recapitulates the spatial and temporal distribution of endogenous Wt1, including expression in the developing heart (21, 26 ).
Our findings demonstrate that tissue hypoxia is one potent stimulus for Wt1 gene activation in the coronary vasculature. This observation and the early rise of Wt1 after LAD ligation indicates that Wt1 expression in the infarcted rat hearts is presumably initiated by reduced tissue oxygenation, which is a major component of cardiac ischemia. The molecular signal(s) that underlie activation of Wt1 during hypoxia remain to be determined. In this context, it is interesting to note that at least two predicted consensus bindings elements (5'-RCGTGV-3') for the HIF-1 are contained in the proximal promoter of the mouse Wt1 gene (Wagner et al., unpublished observations). HIF-1 is therefore a potential candidate for transcriptional activation of Wt1 in the coronary vasculature under reduced tissue oxygenation. However, one must consider that Wt1 expression in the heart vessels persisted beyond the acute phase of myocardial infarction, suggesting that other mechanisms in addition to local tissue hypoxia may be important for the sustained elevation of Wt1 following coronary artery occlusion.
Proliferation of VSMCs and vascular endothelial cells is a critical step in the formation of collaterals from preexisting coronary vessels. The remarkably similar expression patterns of Wt1 and PCNA, as well as PECAM-1, in the coronary vasculature of the ischemic myocardium suggest a role for Wt1 in the proliferative response of these vessels to reduced tissue oxygenation. This assumption is further supported by our finding that VEGF, which is a potent stimulus of vascular endothelial cell proliferation and migration (see refs 46 and 47 for review), was detected in Wt1-positive coronary vessels close to the infarcted tissue. Thus, it is tempting to speculate that Wt1 is one of the transcriptional regulators that are involved in the control of vascular growth in the ischemic myocardium. Consistent with a role for Wt1 in coronary vascular formation, a lack of vessel development in the subepicardial tissue was recently demonstrated in mouse embryos with deficient Wt1 gene (21).
The molecular mechanisms through which Wt1 fulfils its hypothetical functions in coronary vascular formation are unknown. In this regard, a recent study describes the localization of Wt1 protein in chick and quail embryos (48) . In early avian embryos, Wt1 was detected in specific areas of the coelomic mesothelium adjacent to the nephric ducts, the myocardium, or the primordia of the endodermal organs (gut, liver, lungs) (48) . These mesothelial structures showed localized expression of Slug, a zinc-finger transcription factor that has been implicated in epithelial-to-mesenchymal transition (48) . Wt1-positive cells were also observed in the subepicardial mesenchyme of the chick and quail embryos, from where they invaded into the ventricular myocardium (48) . The authors concluded from their observations that Wt1 may allow mesothelial-derived cells to acquire an undifferentiated, pluripotent state, which is critical for de novo formation of epithelial structures from mesodermal tissues (48) . According to this concept, it is possible that Wt1 in the coronary vessels of the ischemic myocardium enables vascular cells to regain a mesenchymal phenotype and to undergo proliferation. Association of Wt1 expression and the ability of cells to proliferate have been suggested in previous studies (49, 50) .
In summary, these findings demonstrate for the first time that Wt1 is expressed de novo in the coronary vasculature of the ischemic myocardium. Our results indicate that Wt1 expression in these vessels is stimulated by reduced tissue oxygenation. We propose that Wt1 plays a role in the proliferative response of the coronary vasculature to regional ischemia, which is part of the neovascularization process. tissue of rat hearts. Ten micrograms of total RNA was used for hybridization with a Wt1 antisense RNA probe. For normalization of Wt1 transcripts, the housekeeping gene U6 small nuclear (sn) RNA was determined in parallel in each sample. The total RNA was obtained from the normal hearts of Wistar Kyoto (WKY) rats and from the hypertrophied left ventricles of rats with spontaneous hypertension (SHR), with activation of the renin-angiotensin system due to transgenic (over)expression of the human renin and angiotensinogen genes (TGR), and with postinfarct remodeling of the heart 6 wk after ligation of the left coronary artery. Wt1 mRNA was similar in the hearts of normal rats (WKY) and in the hypertrophied left ventricles of both SHR and TGR. However, note the more than twofold increase in left ventricular Wt1 mRNA after myocardial infarction (MI). The two Wt1(+17 amino acids) and Wt1(-17aa) isoforms are generated by alternative splicing of exon 5 (number of different animals in each group, n=5). of the left coronary artery (LAD), respectively. RNase protection assays were performed with 10 µg of total RNA in each sample. Small nuclear (sn) RNA was determined in parallel for normalization of the Wt1 expression data. Note the 2.5-to 3-fold elevated Wt1 transcripts in the left ventricular tissue of rats between 1 day and 9 wk after myocardial infarction (MI). No significant differences were detected in Wt1 mRNA between the noninfarcted right ventricles of the LAD-ligated and sham-operated rats (C). *P < 0.05 and **P < 0.01 were considered statistically significant (ANOVA, n=5 each). (b, c) . In addition, Wt1 immunoreactivity was clearly visible at the inner circumference of the coronary vessels in smooth muscle α-actin-negative cells. The distribution of Wt1 and PECAM-1 was, in part, overlapped, suggesting that vascular endothelial cells are capable of expressing Wt1 in response to local tissue ischemia (e, f). The hearts of sham-operated rats showed no overlapping expression of Wt1 and PECAM-1 (data not shown). The depicted immunostainings are representative for the more than 24 tissue sections that were obtained from three different animals each. Appropriate negative controls were performed on sections from infarcted tissue without using primary antibodies. Nuclei were visualized by counterstaining with DAPI (a, d). Scale bars indicate 100 µm (a, b, c, e, f, g) and 20 µm (d, h) . overlaid (b, c) . An overlapping pattern in the coronary vasculature was also observed by double-immunolabeling of Wt1 and vascular endothelial growth factor (VEGF). VEGF and Wt1 immunoreactivity were not detected in the non-infarcted right ventricles of the rats and in the hearts of shamoperated animals (data not shown). Negative controls that were performed on tissue sections from infarcted myocardium without the use of primary antibodies also showed no specific fluorescence (a, d). A total of more than 30 tissue sections that were obtained from three different animals each were examined. Negative control sections (a, d) were counterstained with DAPI for better visualization of the tissue structure. Scale bars indicate  100 µm (a, b, d, e) and 20 µm (c, f) . conditions. Tissue oxygenation was reduced by exposing rats for 6 h either to 8% O 2 or to 0.1% carbon monoxide to mimic anemia. Note the approximately fourfold increase in Wt1 transcripts (+17aa and -17aa isoforms) in the left ventricles of hypoxic (8% O 2 , 0.1% CO) compared with normoxic (20% O 2 ) rats (B). No differences in small nuclear (sn) RNA were observed between the different experimental conditions (A). Immunofluorescent labeling indicates that in addition to the epicardium, Wt1 is also expressed in the vasculature of the hypoxic hearts. In contrast, normoxic rat hearts (20% O 2 ) showed Wt1 immunoreactivity only in the epicardial layer. Double-immunofluorescent labeling of Wt1 (red) and the oxygen-sensitive subunit of hypoxia-inducible factor-1 (HIF-1α) (green) indicate that the two proteins shared an overlapping expression pattern in coronary vessels of the ischemic myocardium 24 h after left coronary artery ligation. Colocalization of Wt1 and HIF-1α is indicated by the yellow staining of cells upon merging the two fluorescence signals (e). High-power magnification (f) reveals nuclear expression of HIF-1α. As negative controls, tissue sections from ischemic rat hearts were incubated without primary antibodies and were counterstained with DAPI (d). Scale bars indicate 100 µm (a-e) and 20 µm (f).
